NX Quanex Building Products CORP

Price (delayed)

$33.77

Market cap

$1.11B

P/E Ratio

13.45

Dividend/share

$0.32

EPS

$2.51

Enterprise value

$1.17B

Quanex Building Products Corporation is an industry-leading manufacturer of components sold to Original Equipment Manufacturers (OEMs) in the building products industry. Quanex designs and produces energy-efficient fenestration products in addition ...

Highlights
The equity has grown by 17% YoY and by 3.7% from the previous quarter
NX's gross margin is up by 11% year-on-year and by 6% since the previous quarter
The debt has grown by 33% YoY but it has contracted by 25% from the previous quarter
Quanex Building Products's net income has decreased by 7% YoY but it has increased by 3.4% QoQ
The stock's price to earnings (P/E) is 29% more than its last 4 quarters average of 10.4
NX's revenue is down by 7% year-on-year

Key stats

What are the main financial stats of NX
Market
Shares outstanding
33M
Market cap
$1.11B
Enterprise value
$1.17B
Valuations
Price to book (P/B)
2.04
Price to sales (P/S)
0.98
EV/EBIT
11.15
EV/EBITDA
7.92
EV/Sales
1.04
Earnings
Revenue
$1.13B
EBIT
$105.18M
EBITDA
$148.05M
Free cash flow
$109.92M
Per share
EPS
$2.51
Free cash flow per share
$3.35
Book value per share
$16.54
Revenue per share
$34.45
TBVPS
$17.49
Balance sheet
Total assets
$831.14M
Total liabilities
$285.59M
Debt
$116.39M
Equity
$545.55M
Working capital
$138.94M
Liquidity
Debt to equity
0.21
Current ratio
2.03
Quick ratio
1.16
Net debt/EBITDA
0.39
Margins
EBITDA margin
13.1%
Gross margin
24.5%
Net margin
7.3%
Operating margin
9.8%
Efficiency
Return on assets
9.9%
Return on equity
16.2%
Return on invested capital
19.1%
Return on capital employed
15.1%
Return on sales
9.3%
Dividend
Dividend yield
0.95%
DPS
$0.32
Payout ratio
12.7%

NX stock price

How has the Quanex Building Products stock price performed over time
Intraday
0.21%
1 week
0.96%
1 month
9.15%
1 year
31.81%
YTD
10.47%
QTD
10.47%

Financial performance

How have Quanex Building Products's revenue and profit performed over time
Revenue
$1.13B
Gross profit
$277.52M
Operating income
$110.7M
Net income
$82.5M
Gross margin
24.5%
Net margin
7.3%
NX's operating margin is up by 13% since the previous quarter and by 8% year-on-year
NX's gross margin is up by 11% year-on-year and by 6% since the previous quarter
NX's operating income is up by 11% QoQ
NX's revenue is down by 7% year-on-year

Growth

What is Quanex Building Products's growth rate over time

Valuation

What is Quanex Building Products stock price valuation
P/E
13.45
P/B
2.04
P/S
0.98
EV/EBIT
11.15
EV/EBITDA
7.92
EV/Sales
1.04
The stock's price to earnings (P/E) is 29% more than its last 4 quarters average of 10.4
The EPS has declined by 6% year-on-year but it has increased by 3.3% since the previous quarter
NX's P/B is 28% higher than its last 4 quarters average of 1.6 and 20% higher than its 5-year quarterly average of 1.7
The equity has grown by 17% YoY and by 3.7% from the previous quarter
The P/S is 40% higher than the 5-year quarterly average of 0.7 and 40% higher than the last 4 quarters average of 0.7
NX's revenue is down by 7% year-on-year

Efficiency

How efficient is Quanex Building Products business performance
The return on invested capital has declined by 25% year-on-year
NX's return on equity is down by 19% year-on-year
The ROA has decreased by 18% YoY
The return on sales has increased by 6% since the previous quarter

Dividends

What is NX's dividend history
DPS
$0.32
Dividend yield
0.95%
Payout ratio
12.7%
Recent dividends

Financial health

How did Quanex Building Products financials performed over time
The total assets is 191% greater than the total liabilities
The total assets is up by 15% year-on-year
NX's total liabilities is down by 11% since the previous quarter but it is up by 10% year-on-year
The debt is 79% less than the equity
The debt has grown by 33% YoY but it has contracted by 25% from the previous quarter
The debt to equity has declined by 30% since the previous quarter but it is up by 11% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.